Pacrinolol

In this article we are going to delve into Pacrinolol, a topic that has captured the attention of many people in recent years. Pacrinolol is a topic that covers a wide range of aspects, from its impact on society to its implications in the business world. Throughout this article, we will look at the different facets of Pacrinolol and explore how it has evolved over time. Furthermore, we will examine its relevance today and discuss its possible impact in the future. From its origins to its contemporary applications, Pacrinolol is a topic that continues to generate interest and debate, and we are excited to dive into its study in this article.

Pacrinolol
Names
IUPAC name
(E)-3--2-hydroxypropoxy]phenyl]but-2-enenitrile
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C23H28N2O4/c1-17(10-12-24)19-5-7-21(8-6-19)29-16-20(26)15-25-13-11-18-4-9-22(27-2)23(14-18)28-3/h4-10,14,20,25-26H,11,13,15-16H2,1-3H3/b17-10+
    Key: BMAJJBHGPUHERB-LICLKQGHSA-N
  • InChI=1/C23H28N2O4/c1-17(10-12-24)19-5-7-21(8-6-19)29-16-20(26)15-25-13-11-18-4-9-22(27-2)23(14-18)28-3/h4-10,14,20,25-26H,11,13,15-16H2,1-3H3/b17-10+
    Key: BMAJJBHGPUHERB-LICLKQGHBO
  • N#C\C=C(\c2ccc(OCC(O)CNCCc1cc(OC)c(OC)cc1)cc2)C
  • C/C(=C\C#N)/C1=CC=C(C=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O
Properties
C23H28N2O4
Molar mass 396.487 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).

Pacrinolol is a beta adrenergic receptor antagonist.[1]

References

  1. ^ Stache, U; Fritsch, W; Fehlhaber, HW (1987). "Synthesis of the highly cardioselective beta-sympatholytic pacrinolol". Arzneimittel-Forschung. 37 (11): 1217–21. PMID 2894210.


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.